Table 3 Significance and fold change for LPC(26:0), total C26:0 and LPC(32:0) for defined patient group comparisons
From: Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy
LPC(26:0) | C26:0 | LPC(32:0) | ||||
|---|---|---|---|---|---|---|
p | FC | p | FC | pa | FC | |
CALD vs NoCALD (all ages) | 0.0001907 | 1.52 | 0.0067250 | 1.21 | 0.0000005 | 2.19 |
CALD vs NoCALD >55 | 0.0000010 | 2.24 | 0.0002741 | 1.45 | 0.0000003 | 3.74 |
AI vs NoAI (all ages) | 0.0000069 | 1.58 | 0.0106273 | 1.16 | 0.0000022 | 2.15 |
AI vs NoAI >55 | 0.0000014 | 2.01 | 0.0008446 | 1.33 | 0.0000008 | 3.13 |
severe vs mild (male) | 0.0005898 | 1.82 | 0.0013877 | 1.4 | 0.0007270 | 2.58 |
severe vs mild (female) | 0.0076843 | 1.43 | 0.0064491 | 1.26 | na | na |